ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 624153 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 624153; 2) Community: the network communities that were significantly associated with the response to NSC 624153; 3) Molecule: the relationships between components within communities and NSC 624153; 4) MDR: the compounds that were significantly associated with the NSC 624153.

NSC Compound Enrichment Correlation
NSC 744331 (2R,11aS)-8- {2-[4-(2-{[(2R,11aS)-C2-di-Fluoro-7-Methoxy-5-oxo-2,3,5,11a-tetrahydro-1-H-benzo[e]-pyrrolo[1,2-a][1,4]diazepine-8-yl}propyl)piperazino]propoxy}-C2-di-fluoro-7-Methoxy-2,3,5,11a-tetrahyd 0.038506707102734 0.53571666
NSC 747451 3,19-Benzylidine-14-deoxy-11,12-didehydroandrographolide 0.038506707102734 0.53640246
NSC 758682 ARTENIMOL 0.038506707102734 0.35426823
NSC 92504 Null 0.038506707102734 0.35882097
NSC 135929 Null 0.0385067071027343 0.47960756
NSC 617309 Null 0.0385067071027343 0.51195625
NSC 623989 Null 0.0385067071027343 0.50119598
NSC 639511 Cyclopentanone, 2-[(dimethylamino)methyl]-5-[(4-methoxy- phenyl)methylene]-, hydrochloride 0.0385203205529754 0.45650905
NSC 736607 Null 0.0385203205529754 0.37477479
NSC 8120 Claviform 0.0385203205529754 0.49177147
Total:80  Current:66    [First] [Prev] [Next] [Last]